Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Experimental Cell Research

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YEXCR.2003.09.027PMID 14729053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Gene Mutation Database (HGMD®): 2003 update

  2003cited by this paper
• Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

  2003cited by this paper
• Regulation of tumor suppressors by nuclear-cytoplasmic shuttling.

  2003cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

  2001cited by this paper
• Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

  2001cited by this paper
• Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

  2001cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• Screening of BRCA1 Mutation Using Immunohistochemical Staining with C‐Terminal and N‐Terminal Antibodies in Familial Ovarian Cancers

  2000cited by this paper
• Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.

  2000cited by this paper
• Identification of a Functional Nuclear Export Sequence in BRCA1*

  2000cited by this paper
• Independence of R/M/N focus formation and the presence of intact BRCA1.

  2000cited by this paper
• Emerging roles of BRCA1 in transcriptional regulation and DNA repair

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

  1999cited by this paper
• BRCA1 is associated with the centrosome during mitosis.

  1998cited by this paper
• Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype.

  1998cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers

  1998cited by this paper
• Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

  1998cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1*

  1996cited by this paper
• Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor*

  1996cited by this paper
• Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

  1996cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Role of nuclear import proteins in maintaining proteostasis and disease pathogenesis.

  2026cites this paper
• BRCA1 Protein Expression in Epithelial Ovarian Cancer and Associated Clinicopathological Factors in Uganda

  2024cites this paper
• Pervasive mislocalization of pathogenic coding variants underlying human disorders.

  2024cites this paper
• The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients

  2024cites this paper
• SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis

  2023cites this paper
• Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays

  2023cites this paper
• Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients

  2023cites this paper
• Pervasive mislocalization of pathogenic coding variants underlying human disorders

  2023cites this paper
• Overexpression of MLF1IP promotes colorectal cancer cell proliferation through BRCA1/AKT/p27 signaling pathway.

  2022cites this paper
• Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?

  2022cites this paper
• BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target

  2021cites this paper
• The Many Faces of Lipids in Genome Stability (and How to Unmask Them)

  2021cites this paper
• MAPS: machine-assisted phenotype scoring enables rapid functional assessment of genetic variants by high-content microscopy

  2021cites this paper
• BRCA1-BRCT Mutations Alter the Subcellular Localization of BRCA1 In Vitro

  2021cites this paper
• BRCA1/P53: Two strengths in cancer chemoprevention.

  2020cites this paper
• Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications

  2020cites this paper
• A Bioconductor workflow for the Bayesian analysis of spatial proteomics

  2019cites this paper
• BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance

  2019cites this paper
• Characterizing BRCA1 Variants Using Multiplex Functional Assays

  2019cites this paper
• Western Analysis of Breast Cancer 1 Protein (BRCA1).

  2019cites this paper
• is included in the Machine learning : life collection

  2019cites this paper
• Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation

  2019cites this paper
• Semi-Supervised Non-Parametric Bayesian Modelling of Spatial Proteomics.

  2019cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer

  2018cites this paper
• The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• A Bayesian mixture modelling approach for spatial proteomics

  2018cites this paper
• Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain

  2018cites this paper
• Characterization of a novel germline BRCA1 splice variant, c.5332+4delA

  2018cites this paper
• The Impact of M1775K Variant in BRCA1 Regulation

  2017cites this paper
• Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance

  2017cites this paper
• The Role of BRCA 1 in DNA Double-strand Break Repair

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line.

  2016cites this paper
• Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes

  2016cites this paper
• Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein

  2016cites this paper
• BRCA1 Circos: a visualisation resource for functional analysis of missense variants

  2015cites this paper
• Protein stability versus function: effects of destabilizing missense mutations on BRCA1 DNA repair activity.

  2015cites this paper
• MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.

  2015cites this paper
• BRCA1 mislocalization associated with breast carcinogenesis and poor prognosis in Taiwanese women

  2015cites this paper
• The Role of BRCT-Containing Proteins BRCA1 and PAXIP1 in Cancer

  2015cites this paper
• EPMA position paper in cancer: current overview and future perspectives

  2015cites this paper
• The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release*

  2015cites this paper
• Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer

  2015influential citation
• Opportunities and hurdles in the treatment of BRCA1-related breast cancer

  2014cites this paper
• The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer

  2014cites this paper
• The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2.

  2014cites this paper
• Deregulation of Microcephalin and ASPM Expression Are Correlated with Epithelial Ovarian Cancer Progression

  2014cites this paper
• Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas.

  2014cites this paper
• ATM, BRCA1, and Aurora A: Mechanisms of G2/M Checkpoint Control in Human Embryonic Stem Cells

  2014cites this paper
• Assessment of DNA-damage repair in breast cancer

  2014cites this paper
• an Additional Method in the Selection of Patients Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as

  2013cites this paper
• MCPH1 protein expression and polymorphisms are associated with risk of breast cancer.

  2013cites this paper
• The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations

  2012cites this paper
• Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome

  2012cites this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012influential citation
• The In Vivo Dynamic Organization of BRCA1‐A Complex Proteins at DNA Damage‐Induced Nuclear Foci

  2012cites this paper
• ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival

  2011cites this paper
• Assessment of human nter and cter BRCA1 mutations using growth and localization assays in yeast

  2011cites this paper
• Therapeutics , Targets , and Chemical Biology p 53-Dependent BRCA 1 Nuclear Export Controls Cellular Susceptibility to DNA Damage

  2011cites this paper
• Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.

  2011cites this paper
• In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein

  2011cites this paper
• p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.

  2011cites this paper
• Mutations in the BRCT binding site of BRCA1 result in hyper-recombination

  2011cites this paper
• A novel role for BRCA1 in regulating breast cancer cell spreading and motility

  2011cites this paper
• Turnover of BRCA1 Involves in Radiation-Induced Apoptosis

  2010cites this paper
• Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach

  2010cites this paper
• BRCA1 16 years later: DNA damage‐induced BRCA1 shuttling

  2010cites this paper
• Novel Roles for 185delAG Mutant BRCA1 in Ovarian Cancer Pathology

  2010cites this paper
• Turnover of BRCA 1 Involves in Radiation-Induced Apoptosis

  2010cites this paper
• Molecular-assisted immunohistochemical optimization.

  2010cites this paper
• BRCA1 16 years later: risk‐associated BRCA1 mutations and their functional implications

  2010cites this paper
• Impact of RING and BRCT Domain Mutations on BRCA1 Protein Stability, Localization and Recruitment to DNA Damage

  2010cites this paper
• Cloning and characterization of a new BRCA1 variant: A role for BRCT domains in apoptosis.

  2010cites this paper
• DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.

  2010cites this paper
• Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.

  2009cites this paper
• Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.

  2009cites this paper
• The Role of BRCA1 in DNA Double-strand Break Repair

  2009cites this paper
• Characterization of cancer‐linked BRCA1‐BRCT missense variants and their interaction with phosphoprotein targets

  2009cites this paper
• Mitochondrial localization, ELK‐1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins

  2009cites this paper
• Prediction of disease-related mutations affecting protein localization

  2009cites this paper
• Cloning and functional identification of two novel BRCA1 splicing variants

  2008cites this paper
• Negative Regulation of AKT Activation by BRCA1.

  2008cites this paper
• Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer

  2008cites this paper
• Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.

  2008cites this paper
• BRCA1 Haploinsufficiency, but not Heterozygosity for a BRCA1-truncating Mutation, Deregulates Homologous Recombination

  2007cites this paper
• Activation of BRCA1/BRCA2-Associated Helicase BACH1 Is Required for Timely Progression through S Phase

  2007cites this paper
• Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as an Additional Method in the Selection of Patients

  2007cites this paper
• Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability

  2007cites this paper
• Aberrant expression of TopBP1 in breast cancer

  2007cites this paper
• Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

  2007cites this paper
• Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.

  2007cites this paper
• A homologue of the breast cancer‐associated gene BARD1 is involved in DNA repair in plants

  2006cites this paper
• Oncogenic conversion of the thyroid hormone receptor by altered nuclear transport

  2006cites this paper
• Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.

  2006influential citation
• 3 - Role of Tumor Suppressor BARD1 in Apoptosis and Cancer

  2006cites this paper
• Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population.

  2005cites this paper